| Primary |
| Product Used For Unknown Indication |
60.0% |
| Pain |
15.3% |
| Analgesic Therapy |
4.7% |
| Back Pain |
3.7% |
| Pain Management |
3.2% |
| Relaxation Therapy |
1.6% |
| Abdominal Pain |
1.1% |
| Arthralgia |
1.1% |
| Arthritis |
1.1% |
| Enterocutaneous Fistula |
1.1% |
| Multiple Sclerosis |
1.1% |
| Neuralgia |
1.1% |
| Rheumatic Disorder |
1.1% |
| Spinal Pain |
1.1% |
| Accidental Exposure To Product |
0.5% |
| Angina Pectoris |
0.5% |
| Breakthrough Pain |
0.5% |
| Cancer Pain |
0.5% |
| Chronic Obstructive Pulmonary Disease |
0.5% |
| Dermatitis |
0.5% |
|
| Wrong Technique In Drug Usage Process |
76.5% |
| Inappropriate Schedule Of Drug Administration |
3.1% |
| Pruritus |
2.0% |
| Withdrawal Syndrome |
2.0% |
| Drug Ineffective |
1.0% |
| Drug Withdrawal Syndrome |
1.0% |
| Exposure During Pregnancy |
1.0% |
| Incorrect Dose Administered |
1.0% |
| Incorrect Drug Administration Duration |
1.0% |
| Malaise |
1.0% |
| Medication Error |
1.0% |
| Muscle Rupture |
1.0% |
| Nausea |
1.0% |
| Overdose |
1.0% |
| Pain |
1.0% |
| Pneumonia |
1.0% |
| Prescribed Overdose |
1.0% |
| Product Adhesion Issue |
1.0% |
| Product Packaging Quantity Issue |
1.0% |
| Product Quality Issue |
1.0% |
|
| Secondary |
| Product Used For Unknown Indication |
47.6% |
| Pain |
17.1% |
| Back Pain |
8.6% |
| Abdominal Pain |
5.3% |
| Enterocutaneous Fistula |
5.3% |
| Neuralgia |
2.7% |
| Analgesic Intervention Supportive Therapy |
1.6% |
| Relaxation Therapy |
1.6% |
| Type 1 Diabetes Mellitus |
1.6% |
| Analgesic Therapy |
1.1% |
| Arthralgia |
1.1% |
| Constipation |
1.1% |
| Multiple Sclerosis |
1.1% |
| Rheumatic Disorder |
1.1% |
| Spinal Pain |
1.1% |
| Breakthrough Pain |
0.5% |
| Hypertension |
0.5% |
| Hypothyroidism |
0.5% |
| Tarsal Tunnel Syndrome |
0.5% |
|
| Wrong Technique In Drug Usage Process |
47.7% |
| Pruritus |
11.4% |
| Urticaria |
11.4% |
| Inappropriate Schedule Of Drug Administration |
9.1% |
| Drug Withdrawal Syndrome |
2.3% |
| Nausea |
2.3% |
| Pain |
2.3% |
| Pneumonia |
2.3% |
| Prescribed Overdose |
2.3% |
| Product Packaging Quantity Issue |
2.3% |
| Somnolence |
2.3% |
| Therapeutic Response Decreased |
2.3% |
| Withdrawal Syndrome |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
75.6% |
| Colon Cancer |
9.8% |
| Impetigo |
7.3% |
| Oral Herpes |
4.9% |
| Cold Sore (Herpetic) |
2.4% |
|
| Pancreatitis |
75.0% |
| Pneumonia |
25.0% |
|
